San Diego, California
United States
53
2025-04-24
The entities that hold a legal rights for patent applications filed by inventor Webber Stephen E.:
Stephen E. Webber from San Diego, US has applied for patents for these inventions. The list has both pending applications and granted patents:
SUBSTITUTED PURINES AS TLR7 AGONISTS
#2 | 2022-10-13SARS-3CL PROTEASE INHIBITORS
#3 | 2022-04-21Crystalline forms of Mnk inhibitors
#4 | 2022-03-31Substituted purines as TLR7 agonists
#5 | 2021-11-04MNK INHIBITORS AND METHODS RELATED THERETO
#6 | 2021-05-27TLR7 agonists
#7 | 2020-04-30Crystalline forms of MNK inhibitors
#8 | 2019-11-28Substituted purines as TLR7 agonists
#9 | 2019-11-07Indoline analogs and uses thereof
#10 | 2019-10-31Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2
#11 | 2019-07-11MNK INHIBITORS AND METHODS RELATED THERETO
#12 | 2019-05-23ISOINDOLINE, AZAISOINDOLINE, DIHYDROINDENONE AND DIHYDROAZAINDENONE INHIBITORS OF MNK1 AND MNK2
#13 | 2018-03-29MNK INHIBITORS AND METHODS RELATED THERETO
#14 | 2018-03-08IMMUNE CHECKPOINT INHIBITORS, COMPOSITIONS AND METHODS THEREOF
#15 | 2017-12-28CK2 inhibitors, compositions and methods thereof
#16 | 2017-12-07Indoline analogs and uses thereof
#17 | 2017-10-05Indoline analogs and uses thereof
#18 | 2017-09-21MNK inhibitors and methods related thereto
#19 | 2017-05-25Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers
#20 | 2017-05-04Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
#21 | 2017-05-04PYRROLO-, PYRAZOLO-, IMIDAZO-PYRIMIDINE AND PYRIDINE COMPOUNDS THAT INHIBIT MNK1 AND MNK2
#22 | 2016-11-03MNK inhibitors and methods related thereto
#23 | 2015-12-31Mnk inhibitors and methods related thereto
#24 | 2013-10-033,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
#25 | 2012-12-20BRIDGED POLYCYCLIC COMPOUNDS
#26 | 2012-11-08Deuterated 5,6-dihydro-1-pyridin-2-one compounds
#27 | 2012-05-173,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-D]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
#28 | 2012-05-10[1,2,4]Thiadiazin-3-yl acetic acid compound and methods of making the acetic acid compound
#29 | 2011-11-103,5-disubstituted and 3,5,7-trisubstituted-3-oxazolo and 3-thiazolo[4,5-]pyrimidin-2-one compounds and prodrugs thereof
#30 | 2010-10-143-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof
#31 | 2010-05-135,6-dihydro-1H-pyridin-2-one compounds
#32 | 2009-12-17Pyrro[1,2-]pyridazinone intermediates
#33 | 2009-12-10[1,2,4]thiadiazine 1,1-dioxide compounds
#34 | 2009-04-23Pyrro[1,2-]pyridazinone compounds
#35 | 2008-11-06Pyridazinone compounds
#36 | 2008-10-163-β-D-ribofuranosylthiazolo[4,5-]pyrimidine nucleosides and uses thereof
#37 | 2008-08-07PYRIDAZINONE COMPOUNDS
#38 | 2008-04-173-beta-D-Ribofuranosylthiazalo [4-5-d] pyrimidine nucleosides and uses thereof
#39 | 2008-04-17PYRIDAZINONE COMPOUNDS
#40 | 2008-03-203-Beta-D-Ribofuranosylthiazolo[ 4,5-D] Pyridimine Nucleosides and Uses Thereof
#41 | 2008-02-07Prodrugs of 5-amino-3-(3′-deoxy-β-D-ribofuranosyl)-thiazolo[4,5-]pyrimidin-2,7-dione
#42 | 2008-02-07Pyrro[1,2-b]pyridazinone compounds
#43 | 2008-01-24Carbonate and carbamate prodrugs of thiazolo[4,5-]pyrimidines
#44 | 2007-05-24Process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-one
#45 | 2007-02-20HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
#46 | 2007-01-25HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
#47 | 2006-08-24Pyridazinone compounds
#48 | 2006-07-203,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
#49 | 2005-11-10HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
#50 | 2005-10-11HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
#51 | 2005-08-183-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereof
#52 | 2005-08-023-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof
#53 | 2005-03-313-B-D-ribofuranosylthiazolo [4,5-] pyrimidine nucleosides and uses thereof
466879 ⎘